Over the mention of delays faced by U.S. firms, AiMeD in a statement argued that, “import licenses for U.S. devices are already faster than for Indian manufacturers, who face mandatory inspections unlike overseas firms.”
from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/8rpS1lz
0 Comments